ADVANCED BIOLOGICAL LABORATORIES SA Société Anonyme

About ADVANCED BIOLOGICAL LABORATORIES SA Société Anonyme

Advanced Biological Laboratories SA, a Luxembourg public limited company, plays a central role in the governance of ABL Diagnostics, the Euronext Paris-listed subsidiary. As the controlling shareholder and a reference board-level stakeholder, ABL SA has become the key strategic anchor behind the French diagnostics company. Market documents and financial reports consistently identify it as the majority owner, giving it significant influence over ABL Diagnostics’ industrial direction, financial policy, and capital structure. ABL Diagnostics operates in molecular diagnostics, clinical biology, and software solutions for laboratory and patient data management, areas in which the parent company brings long-standing expertise and an international development outlook. From a governance perspective, Advanced Biological Laboratories SA has been instrumental in the capital operations and structural changes that shaped ABL Diagnostics in recent years. It is referenced in financial disclosures as the majority shareholder and in communications relating to temporary share transfers and share disposals, highlighting its weight within the shareholder base. This position gives the company an important responsibility in strategic continuity, financing, and support for growth initiatives, particularly in microbiological diagnostics, genotyping, and digital tools for laboratories. Built on biomedical and software expertise, ABL SA has established itself as a leading industrial shareholder capable of combining product innovation, regulatory structuring, and commercial expansion.